Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M. Jones, Michael P. Busch|JAMA|2021Cited by 218
Occupational and industry prevalence of new long‐term symptoms within American Red Cross blood donors with and without history of SARS‐CoV‐2 infectionDeja Edwards, Sharon Saydah, Dallas S. Shi et al.|American Journal of Industrial Medicine|2024Cited by 0